KUMAI Takumi 熊井琢美

Researcher Number	00596306
Affiliation *help	2016 : 旭川医科大学, 医学部, 助教 2012 – 2014 : 旭川医科大学, 医学部, 助教 2012 : 旭川医科大学, 大学病院, その他
Research Field	Principal Investigator Otorhinolaryngology Except Principal Investigator Otorhinolaryngology
Keywords	Principal Investigator ペプチドワクチン / 腫瘍免疫 / 頭頸部癌 / ヘルパーT細胞 / 腫瘍抗原 / c-Met / EGFR阻害薬 / 国際情報交換 / EGFR / 分子標的薬 / ペプチドワクチン療法 / HLA … More Except Principal Investigator … More

頭頸部癌に対する分子標的薬を中心としたアジュバントによる免疫療法の開発Principal InvestigatorOngoing
- Principal Investigator
  
  熊井琢美
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Asahikawa Medical College
A foundational study for targeted therapy against EB virus and tumor growth factor in nasal NK/T-cell lymphoma
- Principal Investigator
  
  HARABUCHI Yasuaki
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Asahikawa Medical College
HER family targeted immunotherapy against head and neck squamous cancerPrincipal Investigator
- Principal Investigator
  
  KUMAI Takumi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Asahikawa Medical College

All 2015 2014 2013 Other

All Journal Article Presentation

[Journal Article] CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.2015
- Author(s)
  Takumi Kumai, Toshihiro Nagato, Hiroya Kobayashi, Yuki Komabayashi, Seigo Ueda, Kan Kishibe, Takayuki Ohkuri, Miki Takahara, Esteban Celis, Yasuaki Harabuchi
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume : 64 Issue : 6 Pages : 697-705
- Language
  English
- Peer Reviewed / Open Access / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24390385, KAKENHI-PROJECT-15H04986
[Journal Article] ヘルパーT 細胞と免疫アジュバントを用いた頭頸部癌免疫治療の開発2014
- Author(s)
  熊井　琢美、長門　利純、高原　幹、小林　博也、原渕　保明
- Journal Title
  
  耳鼻咽喉科免疫アレルギー
  
  Volume : 32 Issue : 3 Pages : 185-190
- Language
  Japanese
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24791735
[Journal Article] EGFR阻害薬はHERファミリー特異的T細胞の抗腫瘍効果を増強する2013
- Author(s)
  T Kumai, Y Matsuda, K Oikawa, N Aoki, S Kimura, Y Harabuchi, E Celis and H Kobayashi
- Journal Title
  
  British Journal of Cancer
  
  Volume : 109 Issue : 6 Pages : 2155-2166
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24791735
[Presentation] EGFR反応性CD4陽性ヘルパーT細胞クローンの樹立及び EGFR阻害薬のアジュバントとしての有用性2013
- Author(s)
  熊井琢美
- Organizer
  日本耳鼻咽喉科学会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-24791735
[Presentation] EGFR inhibition augments anti-tumor immune responses by HER family-specific human CD4 helper T cells in vitro
- Author(s)
  熊井琢美
- Organizer
  AACR annual meeting 2013
- Place of Presentation
  Washington, D.C.
- Data Source
  KAKENHI-PROJECT-24791735
[Presentation] EGFR inhibition augments anti-tumor immune responses by HER family-specific human CD4 helper T cells
- Author(s)
  熊井琢美
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-24791735
[Presentation] 腫瘍免疫におけるアジュバントとしての EGFR阻害薬の有用性
- Author(s)
  熊井琢美
- Organizer
  第31回日本耳鼻咽喉科免疫アレルギー学会
- Place of Presentation
  倉敷
- Data Source
  KAKENHI-PROJECT-24791735
[Presentation] EGFR inhibition augments anti-tumor immune responses by HER family-specific human CD4 helper T cells in vitro
- Author(s)
  熊井琢美
- Organizer
  AACR annual meeting 2013
- Place of Presentation
  Washington, D.C.
- Data Source
  KAKENHI-PROJECT-24791735
[Presentation] 鼻性NK/T 細胞リンパ腫における新規c-MetヘルパT細胞エピトープの探索
- Author(s)
  熊井琢美
- Organizer
  第46回北海道病理談話会
- Place of Presentation
  北海道
- Data Source
  KAKENHI-PROJECT-24390385
[Presentation] C-C chemokine receptor 4 is a remarkable molecule for novel targeted therapy against nasal natural killer/T-cell lymphoma
- Author(s)
  Toshihiro Nagato, Takumi Kumai, Hiroya Kobayashi, Yuki Komabayashi, Seigo Ueda, Kan Kishibe, Miki Takahara, Yasuaki Harabuchi
- Organizer
  16th International Symposium on EBV
- Place of Presentation
  Brisbane, Australia
- Year and Date
  2014-07-16 – 2014-07-19
- Data Source
  KAKENHI-PROJECT-24390385

1. HARABUCHI Yasuaki (80208686)

# of Collaborated Projects : 1results

# of Collaborated Products : 2results
2. TAKAHARA Miki (50322904)

# of Collaborated Projects : 1results

# of Collaborated Products : 2results
3. KISHIBE Kan (80447101)

# of Collaborated Projects : 1results

# of Collaborated Products : 2results
4. KOBAYASHI Hiroya (90280867)

# of Collaborated Projects : 1results

# of Collaborated Products : 2results
5. UEDA Seigo (90447102)

# of Collaborated Projects : 1results

# of Collaborated Products : 2results
6. NAGATO Toshihiro (80431419)

# of Collaborated Projects : 1results

# of Collaborated Products : 2results
7. KOMABAYASHI Yuki (40548864)

# of Collaborated Projects : 1results

# of Collaborated Products : 2results

KUMAI Takumi 熊井 琢美

Research Projects

Research Products

Co-Researchers

頭頸部癌に対する分子標的薬を中心としたアジュバントによる免疫療法の開発Principal InvestigatorOngoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

A foundational study for targeted therapy against EB virus and tumor growth factor in nasal NK/T-cell lymphoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

HER family targeted immunotherapy against head and neck squamous cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.2015

Author(s)

Journal Title

Language

Data Source

[Journal Article] ヘルパーT 細胞と免疫アジュバントを用いた頭頸部癌免疫治療の開発2014

Author(s)

Journal Title

Language

Data Source

[Journal Article] EGFR阻害薬はHERファミリー特異的T細胞の抗腫瘍効果を増強する2013

Author(s)

Journal Title

Language

Data Source

[Presentation] EGFR反応性CD4陽性ヘルパーT細胞クローンの樹立 及び EGFR阻害薬のアジュバントとしての有用性2013

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] EGFR inhibition augments anti-tumor immune responses by HER family-specific human CD4 helper T cells in vitro

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] EGFR inhibition augments anti-tumor immune responses by HER family-specific human CD4 helper T cells

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 腫瘍免疫におけるアジュバントとしての EGFR阻害薬の有用性

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] EGFR inhibition augments anti-tumor immune responses by HER family-specific human CD4 helper T cells in vitro

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 鼻性NK/T 細胞リンパ腫における新規c-MetヘルパT細胞エピトープの探索

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] C-C chemokine receptor 4 is a remarkable molecule for novel targeted therapy against nasal natural killer/T-cell lymphoma

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

KUMAI Takumi 熊井琢美

[Presentation] EGFR反応性CD4陽性ヘルパーT細胞クローンの樹立及び EGFR阻害薬のアジュバントとしての有用性2013